Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal AI generates virtual population for tumor microenvironment modeling.

Cell·2025
Same author

Longitudinal retrospective study of real-world adherence to colorectal cancer screening before and after the COVID-19 pandemic in the USA.

BMJ public health·2025
Same author

Antidepressant Use Before, During, and After Pregnancy.

JAMA network open·2025
Same author

Exposure to sugar rationing in the first 1000 days of life protected against chronic disease.

Science (New York, N.Y.)·2024
Same author

Value-Based Contracting in Clinical Care.

JAMA health forum·2024
Same author

Artificial intelligence in Medicare: utilization, spending, and access to AI-enabled clinical software.

The American journal of managed care·2024

Related Experiment Video

Updated: Jun 2, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Evaluating the Consequences of a Hypertension Management Incentive.

Claire Boone1, Ari Robicsek2,3

  • 1Department of Economics and Department of Equity, Ethics, and Policy, McGill University, Montreal, Quebec, Canada.

JAMA Internal Medicine
|June 1, 2026
PubMed
Summary

Financial incentives for hypertension control showed minimal impact on overall patient outcomes but led to increased documented control in specific subgroups due to selective blood pressure remeasurement. This approach also saw reduced medication adjustments and increased cardiovascular hospitalizations.

Related Experiment Videos

Last Updated: Jun 2, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Area of Science:

  • Health Services Research
  • Clinical Quality Improvement
  • Cardiovascular Medicine

Background:

  • Financial incentives tied to quality metrics are common but their real-world impact on patient care is complex.
  • Isolating the effects of these incentives on clinical decisions and patient health outcomes is a persistent challenge.

Purpose of the Study:

  • To assess the association between a physician-facing quality metric and financial incentive for hypertension control and subsequent clinical decisions and patient health outcomes.
  • To evaluate the impact of financial incentives on hypertension management in a large US health system.

Main Methods:

  • A quasi-experimental, difference-in-differences study design was employed in a large US health system.
  • Compared outcomes at practices that adopted a hypertension control financial incentive versus those that did not, before and after incentive adoption (2021 vs. 2022-2023).
  • Included patients aged 18-85 with diagnosed hypertension, analyzing blood pressure measurements, medication adjustments, and cardiovascular hospitalizations.

Main Results:

  • The financial incentive was associated with a small increase in blood pressure remeasurement (1.9 pp) in the overall hypertensive population, with no significant changes in overall hypertension control, medication use, or cardiovascular hospitalizations.
  • In patients with marginally high blood pressure (systolic 140-145 mm Hg), the incentive increased documented blood pressure control (4.1 pp) driven by increased remeasurement (5.6 pp).
  • This subgroup also showed reduced antihypertensive medication dose adjustments (-1.1 pp) and a significant increase in 3-month hospitalization risk for stroke or acute coronary syndrome (0.25 pp), rising to 0.52 pp at 1 year.

Conclusions:

  • The quality metric and financial incentive had minimal impact on measured outcomes for the general hypertensive population.
  • For patients with marginally elevated blood pressure, the incentive led to increased documented control through selective measurement, decreased medication adjustments, and a concerning rise in cardiovascular hospitalizations.